
Adding pembrolizumab to standard concurrent chemoradiotherapy significantly improves overall survival in patients with high-risk, locally advanced cervical cancer.


coremsg

Patients with locally advanced cervical cancer were randomized to receive either pembrolizumab or placebo in combination with standard concurrent chemoradiotherapy.

Pembrolizumab Plus CCRT Improves Overall Survival

pembrolizumab-combined-with-chemoradiotherapy-significantly-improves-overall-survival-in-patients-with-high-risk-locally-advanced-cervical-cancer


Pembrolizumab Combined with Chemoradiotherapy Significantly Improves Overall Survival in Patients with High-Risk Locally Advanced Cervical Cancer
